Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts

BACKGROUND: There are no data comparing the 6–9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens containing bedaquiline (B, BDQ) and linezolid (L, LZD). METHODS: Six-month post end-of-treatment outcomes were compared between Nix-TB (n = 109) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Oelofse, S., Esmail, A., Diacon, A. H., Conradie, F., Olayanju, O., Ngubane, N., Howell, P., Everitt, D., Crook, A. M., Mendel, C. M., Wills, G. H., Olugbosi, M., del Parigi, A., Sun, E., Calatroni, A., Spigelman, M., Dheda, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171246/
https://www.ncbi.nlm.nih.gov/pubmed/34049607
http://dx.doi.org/10.5588/ijtld.21.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171246/
https://www.ncbi.nlm.nih.gov/pubmed/34049607
http://dx.doi.org/10.5588/ijtld.21.0035

Ejemplares similares